2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1124237300 MD, PHD
Verify on CMS →

CHARLES WYKOFF, MD, PHD

Retina Specialist (Ophthalmology) Physician in BELLAIRE, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
595
Medicare Part D claims · 204 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.4/100
▲ 13 pts above national avg 83.1 · [object Object]
Industry payments
$394.9K
122 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: CHARLES WYKOFF, MD, PHD is a Retina Specialist (Ophthalmology) Physician ([object Object]) practicing in BELLAIRE, Texas with a Medicare Part D prescribing footprint of 595 claims across 204 beneficiaries — 44% brand-name prescribing . Their CMS MIPS Final Score of 96.4/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $394.9K across 122 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: CHARLES WYKOFF, MD, PHD reported a CMS MIPS final score of 96.4 out of 100, above the 83.1 national average, and filed 595 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

CHARLES WYKOFF, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

CHARLES WYKOFF, MD, PHD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 05/22/2007

NPI 1124237300

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

595 7% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

96.4/100 13.300000000000011% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Texas providers

Texas providers

Retina Specialist (Ophthalmology) Physician share within Texas

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within Texas

Medicare quality performance — MIPS

CHARLES WYKOFF, MD, PHD's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
96.4/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 96.4/100 vs national avg 83.1

0%100%National avg83%96.4%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 96.4/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHARLES WYKOFF, MD, PHD is a Retina Specialist (Ophthalmology) Physician provider practicing in BELLAIRE, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, PHD. NPI: 1124237300. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

CHARLES WYKOFF, MD, PHD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD, PHD credentials at 4460 BISSONNET ST STE 200, BELLAIRE, TX, 77401, with a listed phone of (713) 524-3434. NPI 1124237300 was issued on 05/22/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WYKOFF most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 595 prescription claims written by this provider, covering 204 Medicare beneficiaries and totaling roughly $40K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.4/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4460 BISSONNET ST STE 200
BELLAIRE, TX 77401

Provider Details

NPI 1124237300
Specialty Retina Specialist (Ophthalmology) Physician
Credentials MD, PHD
Gender Male
NPI Issued 05/22/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.4
Final Score
Avg: 83.1
100
Quality
88
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where CHARLES WYKOFF, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

RETINA CONSULTANTS OF HOUSTON PLLC
BELLAIRE, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHARLES WYKOFF, MD, PHD. Source: openpaymentsdata.cms.gov.

Total received

$394.9K

Largest payer

EyePoint Pharmaceuticals US, Inc.

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to CHARLES WYKOFF, MD, PHD. To verify CHARLES WYKOFF, MD, PHD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

CHARLES WYKOFF, MD, PHD — brand share 44.0%
Specialty average (est.)

44% brand-name claims vs 56% generic, on 595 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

595
Total Claims
$40K
Total Drug Cost
204
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
883
Total Day Supply
23,192
Brand vs Generic
44% brand / 56% generic
Brand Drug Cost
$30K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
1.70
Gender Split
52% female / 48% male
Age Distribution
<65: 13, 65-74: 95, 75-84: 69, 85+: 27

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prednisolone Acetate
106
Latanoprost
105
Ketorolac Tromethamine
84
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
50
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
49
Prolensa
Bromfenac Sodium
26
Gatifloxacin
24
Timolol Maleate
16
Dorzolamide Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How CHARLES WYKOFF, MD, PHD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

CHARLES WYKOFF, MD, PHD's 595 claims are above the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as WYKOFF.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHARLES WYKOFF, MD, PHD's specialty?
CHARLES WYKOFF, MD, PHD specializes in Retina Specialist (Ophthalmology) Physician and practices in BELLAIRE, Texas. Credentials: MD, PHD.
How much does CHARLES WYKOFF, MD, PHD prescribe under Medicare Part D?
In 2023, CHARLES WYKOFF, MD, PHD wrote 595 Medicare Part D claims totaling $40K in drug costs for 204 beneficiaries.
What is CHARLES WYKOFF, MD, PHD's Medicare quality score?
CHARLES WYKOFF, MD, PHD has a CMS MIPS Final Score of 96.4/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CHARLES WYKOFF, MD, PHD located?
CHARLES WYKOFF, MD, PHD is located at 4460 BISSONNET ST STE 200, BELLAIRE, TX, 77401. Phone: (713) 524-3434.
What is CHARLES WYKOFF, MD, PHD's NPI number?
CHARLES WYKOFF, MD, PHD's National Provider Identifier (NPI) is 1124237300, issued on 05/22/2007.
Does CHARLES WYKOFF, MD, PHD prescribe more brand-name or generic drugs?
CHARLES WYKOFF, MD, PHD's prescribing is 44% brand-name and 56% generic drugs by claim count, with $30K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does CHARLES WYKOFF, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, CHARLES WYKOFF, MD, PHD's most frequently prescribed drugs include Prednisolone Acetate, Latanoprost, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHARLES WYKOFF, MD, PHD accept Medicare?
CHARLES WYKOFF, MD, PHD appears in CMS Medicare data with 595 Part D claims and 204 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHARLES WYKOFF, MD, PHD's credentials?
CHARLES WYKOFF, MD, PHD's NPI is 1124237300 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology